Publications

5538 Results

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

Authors
TA Gooley;W Leisenring;J Crowley;BE Storer
Journal / Conference
Statistics in Medicine 18:695-706
Year
1999
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8006

Methylation status of the Epstein-Barr virus major latent promoter C in latrogenic B cell lymphoproliferative disease

Authors
Q Tao;LJ Swinnen;J Yang;G Srivastava;KD Robertson;RF Ambinder
Journal / Conference
American Journal of Pathology 155(2):619-625
Year
1999
Research Committee(s)
Lymphoma

P73 mutations and expression in adult de novo acute myelogenous leukemia

Authors
DL Stirewalt;B Clurman;FR Appelbaum;CL Willman;JP Radich
Journal / Conference
Leukemia 13:985-990
Year
1999
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600

Acute leukemias: a paradigm for the integration of new technologies in diagnosis and classification

Authors
CL Willman
Journal / Conference
Modern Pathology 12(1):218-228
Year
1999
Research Committee(s)
Leukemia

Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31)

Authors
WB Green;ML Slovak;IM Chen;M Pallavicini;JL Hecht;CL Willman
Journal / Conference
Leukemia 13:1960-1971
Year
1999
Research Committee(s)
Leukemia

High dose therapy and the age factor in multiple myeloma: evidence vs politics

Authors
B Barlogie;A Badros;D Avers;S Salmon;J Jacobson;M LeBlanc;J Crowley
Journal / Conference
Blood 94(10)Suppl.1:715a(#3157)part_1_of_2
Year
1999
Research Committee(s)
Myeloma

Long term follow-up on SWOG 8624, addressing the role of glucocorticoid dose intensity for remission induction, interferon for maintenance in responders, and dexamethasone + interferon for primary treatment failures

Authors
S Salmon;T Grogan;B Barlogie;J Crowley
Journal / Conference
Blood 94(10)Suppl.1:315a(#1410)part_1_of_2
Year
1999
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8624

Planned melphalan-total body irradiation (MEL-TBI) - based allogeneic transplantation for multiple myeloma (MM) up t age 55: an intergroup experience (CALGB, ECOG and SWOG) under the auspices of the Southwest Oncology Group (SWOG 9321)

Authors
R Desika;S Salmon;K Anderson;R Kyle;J Crowley;B Barlogie
Journal / Conference
Blood 94(10)Suppl.1:346a(#1546)part_1_of_2
Year
1999
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9321

Transformation to Richter's syndrome or prolymphocytic leukemia (PLL), and other second hematologic malignancies in patients iwth chronic lymphocytic leukemia (CLL): an Intergroup study (CALGB 9011)

Authors
VA Morrison;KR Rai;BL Peterson;JE Kolitz;L Elias;JD Hines;L Shepherd;RA Larson;CA Schiffer
Journal / Conference
Blood 94(10)Suppl.1:539a(#2410)part_1_of_2
Year
1999
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9108 (CALGB-9011)

Docetaxel (Taxotere) and estramustine versus mitoxantrone and prednisone for hormone-refractory prostate cancer: scientific basis and design of Southwest Oncology Group study 9916

Authors
M Hussain;D Petrylak;E Fisher;C Tangen;D Crawford
Journal / Conference
Seminars in Oncology 26(5):55-60(Suppl.17)
Year
1999
Research Committee(s)
Genitourinary
Study Number(s)
S9916